Cymra Life Sciences specially formulated chronic pain formulation. It is an oral solution of cannabis oil and is only available through prescription on the SAS Cat B.
10mg/ml THC: 10mg/ml CBD
10mg/ml THC : 25mg/ml CBD
Our products are only available through the Therapeutic Goods Administration (TGA) Special Access Scheme (Cat B) or through the Authorised Prescriber scheme. Cymra Life Sciences can not provide medical cannabis products to individuals directly under any circumstances.
Physicians will need to submit an application under the Special Access Scheme or the Authorised Prescriber Scheme. Further information on the application process can be found on the TGA website. If you’re a physician and need help with the application process, get in touch and we can help.